Chemours (CC)
(Real Time Quote from BATS)
$26.86 USD
-0.17 (-0.63%)
Updated Apr 26, 2024 10:20 AM ET
5-Strong Sell of 5 5
B Value A Growth F Momentum A VGM
Chemours (CC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$30.50 | $40.00 | $26.00 | 12.84% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for Chemours comes to $30.50. The forecasts range from a low of $26.00 to a high of $40.00. The average price target represents an increase of 12.84% from the last closing price of $27.03.
Analyst Price Targets (8 )
Broker Rating
Chemours currently has an average brokerage recommendation (ABR) of 2.63 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 3.13 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, one is Strong Buy and one is Buy. Strong Buy and Buy each account for 12.5% of all recommendations. A month ago, Buy represented 12.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 0 | 1 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 6 | 6 | 6 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 1 | 1 | 0 |
ABR | 2.63 | 2.63 | 3.13 | 2.88 | 2.38 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/9/2024 | BMO Capital Markets | John P Mcnulty | Strong Sell | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.63 |
ABR (Last week) | 2.63 |
# of Recs in ABR | 8 |
Average Target Price | $30.50 |
LT Growth Rate | NA |
Industry | Chemical - Diversified |
Industry Rank by ABR | 93 of 252 |
Current Quarter EPS Est: | 0.25 |